Skip to search formSkip to main contentSkip to account menu

Almitrine

Known as: 2,4-Bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine, Almitrin, Almitrinum 
A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Background Intravenous almitrine, which augments hypoxic pulmonary vasoconstriction, is used for short‐term improvement of… 
1998
1998
Background The partition of pulmonary blood flow between normal and shunting zones is an important determinant of oxygen tension… 
1989
1989
The hypothesis that augmentation of the carotid chemoreceptor response to hypoxia by almitrine is due in part to an increased… 
1989
1989
We assessed respiratory muscle response patterns to chemoreceptor stimuli (hypercapnia, hypoxia, normocapnic hypoxia, almitrine… 
1986
1986
Almitrine bismesylate was studied for its effects on hypoxemia in 67 patients with chronic obstructive lung disease in a placebo… 
1985
1985
1 Van Ballegooie E, Hooymans JMH, Timmerman Z, et al. Rapid deterioration of retinopathy during treatment with continuous… 
1984
1984
Almitrine at a low dose of 100 mg orally significantly raises PaO2 and lowers PaCO2 in patients with chronic obstructive… 
1983
1983
1. Almitrine, an agonist of peripheral chemoreceptors, has been shown to be effective in lowering PaCO2 in patients with chronic… 
1982
1982
: In anaesthetized rats studied in a body plethysmograph, 1-(4'6-diallylamino-2'-triazinyl)-4(bis parafluorobenzydryl) piperazine…